These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 22547614

  • 1. Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
    Podos SD, Thanassi JA, Leggio M, Pucci MJ.
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3812-8. PubMed ID: 22547614
    [Abstract] [Full Text] [Related]

  • 2. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A, Jurado A, Marco F, Almela M, Ortega M, Mensa J.
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [Abstract] [Full Text] [Related]

  • 3. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J, Vidaillac C, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    von Eiff C, Peters G.
    J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
    [Abstract] [Full Text] [Related]

  • 6. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms.
    Tellis M, Joseph J, Khande H, Bhagwat S, Patel M.
    J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.
    Pucci MJ, Podos SD, Thanassi JA, Leggio MJ, Bradbury BJ, Deshpande M.
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2860-71. PubMed ID: 21464250
    [Abstract] [Full Text] [Related]

  • 9. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
    Tang HJ, Chen CC, Ko WC, Yu WL, Chiang SR, Chuang YC.
    Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Abb J.
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):319-21. PubMed ID: 12151194
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C, Caillon J, Le Mabecque V, Miegeville AF, Donnio PY, Bugnon D, Potel G.
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [Abstract] [Full Text] [Related]

  • 12. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
    Bogdanovich T, Esel D, Kelly LM, Bozdogan B, Credito K, Lin G, Smith K, Ednie LM, Hoellman DB, Appelbaum PC.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis.
    Presterl E, Lassnigg A, Eder M, Reichmann S, Hirschl AM, Graninger W.
    Int J Artif Organs; 2007 Sep; 30(9):798-804. PubMed ID: 17918125
    [Abstract] [Full Text] [Related]

  • 15. Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.
    Baldoni D, Haschke M, Rajacic Z, Zimmerli W, Trampuz A.
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1142-8. PubMed ID: 19075065
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
    Hashem AA, Abd El Fadeal NM, Shehata AS.
    J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
    [Abstract] [Full Text] [Related]

  • 18. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.
    Robertson GT, Bonventre EJ, Doyle TB, Du Q, Duncan L, Morris TW, Roche ED, Yan D, Lynch AS.
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2324-34. PubMed ID: 18443106
    [Abstract] [Full Text] [Related]

  • 19. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
    Grohs P, Kitzis MD, Gutmann L.
    Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.
    Lee SY, Fan HW, Sutherland C, DeRyke AC, Nicolau DP.
    Drugs R D; 2007 Jan; 8(2):69-77. PubMed ID: 17324004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.